OPEN TOPIC - Expeditionary Biologics-on-Demand (BOND)
ID: CBD254-011Type: BOTH
Overview

Topic

OPEN TOPIC - Expeditionary Biologics-on-Demand (BOND)

Agency

Agency: DODBranch: CBD

Program

Type: SBIRPhase: BOTH

Topic Link

https://www.dodsbirsttr.mil/topics-app/

Additional Information

https://www.dodsbirsttr.mil/topics-app/
Timeline
    Description

    The Department of Defense (DOD) is seeking proposals for the Small Business Innovation Research (SBIR) program focused on the development of an OPEN TOPIC - Expeditionary Biologics-on-Demand (BOND) system. The primary objective is to create a portable, high-performance system for on-demand protein production that maximizes purity, potency, and quality through advanced automation and machine learning techniques. This initiative aims to enhance supply chain resilience and medical countermeasure capabilities by enabling localized production of diverse biologics, including therapies and vaccines, particularly in forward-deployed locations. The solicitation is currently in pre-release status, with an open date of January 7, 2026, and a close date of January 28, 2026. Interested parties can find more information and submit proposals through the DOD SBIR website at https://www.dodsbirsttr.mil/topics-app/.

    Files
    Title
    Posted
    1762382887965.pdf
    The CBD254-011 solicitation seeks proposals for the development of an Expeditionary Biologics-on-Demand (BOND) system. The core objective is to create a portable, high-performance system for point-of-care protein production, emphasizing maximized purity, potency, and quality through automated process control, machine learning, and real-time data analytics. This technology aims to enhance supply chain resilience and medical countermeasure capabilities by enabling on-site production of therapies, vaccines, and diagnostics. Phase I involves a feasibility study on existing BOND platforms, focusing on high-purity protein production and AI/ML analytics. Phase II requires proposals for a robust, portable system capable of GMP-like protein production, demonstrating reproducibility and scalability. The ultimate goal in Phase III is an FDA-ready BOND device that can meet or surpass existing production methods for approved proteins.
    1762387305120.pdf
    The CBD254-011 solicitation seeks proposals for an
    1762560121424.pdf
    The CBD254-011
    1762646513765.pdf
    The CBD254-011
    1762819318405.pdf
    The CBD254-011 solicitation seeks proposals for an “OPEN TOPIC - Expeditionary Biologics-on-Demand (BOND)” system to develop portable, high-performance, point-of-care protein production. The objective is to maximize protein purity, potency, and quality through automated process control, incorporating soft sensors, machine learning, and real-time data analytics. This technology aims to enhance supply chain resilience and medical countermeasure capabilities by enabling on-site production of therapies, vaccines, and diagnostics, similar to the impact of 3D printing. The primary challenge is ensuring consistent batch quality and reproducibility to meet regulatory standards, which integrated analytics and machine learning may address. Phase I involves feasibility studies using existing BOND platforms to produce high-purity proteins, explore AI/ML analytics, or propose novel biologics. Phase II requires proposals for a robust, portable, GMP-like BOND system, demonstrating reproducible, scalable, and high-quality throughput, with potential development in ML/AI processing, sensor validation, and lysate optimization. Phase III aims for an FDA-ready BOND device capable of meeting or surpassing existing FDA-approved protein production methods.
    1762905703719.pdf
    The CBD254-011 solicitation seeks proposals for developing a portable, high-performance Expeditionary Biologics-on-Demand (BOND) system. The objective is to maximize protein purity, potency, and quality through automated process control, machine learning, and real-time data analytics. This technology aims to enable on-site production of diverse therapies, vaccines, diagnostics, and detection biologics, enhancing supply chain resilience and broadening medical countermeasure capabilities, particularly in forward-deployed locations. Phase I focuses on feasibility studies using existing BOND platforms to produce high-purity proteins and explore AI/ML analytic techniques. Phase II requires proposals for a robust, portable system capable of producing GMP-like protein, demonstrating reproducible, scalable, and high-quality throughput. Phase III's goal is a BOND device ready for FDA evaluation, capable of meeting or surpassing existing production methods of approved FDA proteins.
    1762992129270.pdf
    The CBD254-011 "OPEN TOPIC - Expeditionary Biologics-on-Demand (BOND)" solicitation seeks proposals for developing a portable, high-performance BOND system. The objective is to maximize protein purity, potency, and quality through automated process control, incorporating soft sensors, machine learning, and real-time data analytics. Such systems offer advantages like diverse therapies, vaccines, diagnostics, and streamlined delivery, eliminating cold-chain requirements, and enabling rapid scaling. Phase I focuses on feasibility studies using existing BOND platforms, exploring protein production consistency, glycosylation, lysate development, AI/ML analytics, and novel anti-infectious biologics. Phase II requires proposals for a robust, portable system capable of producing GMP-like protein, demonstrating a ruggedized platform with reproducible, scalable, and high-quality throughput. Phase III aims for a BOND device ready for FDA evaluation, capable of meeting or surpassing existing FDA-approved protein production methods.
    1763078525247.pdf
    The CBD254-011 "OPEN TOPIC - Expeditionary Biologics-on-Demand (BOND)" solicitation seeks to develop a portable, high-performance system for point-of-care protein production. The objective is to maximize protein purity, potency, and quality through automated process control, machine learning, and real-time data analytics. This technology aims to enable on-demand distributed protein production, offering advantages in creating diverse therapies, vaccines, and diagnostics, while enhancing supply chain resilience and medical countermeasure capabilities. Phase I involves feasibility studies using existing BOND platforms, focusing on protein purity, glycosylation, lysate development, AI/ML analytics, or novel anti-infectious biologics. Phase II requires proposals for robust, portable BOND systems capable of producing GMP-like proteins, demonstrating ruggedized platforms with reproducible, scalable, and high-quality throughput. Phase III aims for a BOND device ready for FDA evaluation, capable of meeting or surpassing existing FDA-approved protein production methods.
    1763164917103.pdf
    The CBD254-011 solicitation seeks proposals for an Expeditionary Biologics-on-Demand (BOND) system to enable portable, high-performance protein production at the point of care. The objective is to maximize protein purity, potency, and quality through automated process control, machine learning, and real-time data analytics. This technology aims to enhance supply chain resilience, provide diverse therapies, vaccines, and diagnostics, and enable on-site production in forward-deployed locations, similar to 3D printing's impact on manufacturing. Phase I focuses on feasibility studies and advancing Technology Readiness Levels. Phase II requires proposals for a robust, portable BOND system capable of producing GMP-like proteins with reproducible, scalable, and high-quality throughput. Phase III aims for an FDA-evaluable BOND device capable of meeting or surpassing existing FDA-approved protein production methods, demonstrating its readiness for manufacturing replicate platforms and multiple batch runs for product evaluation.
    1763337712294.pdf
    The CBD254-011
    1763510524602.pdf
    The CBD254-011 solicitation seeks proposals for an “OPEN TOPIC - Expeditionary Biologics-on-Demand (BOND)” system to develop portable, high-performance, point-of-care protein production. The objective is to maximize protein purity, potency, and quality through automated process control, incorporating soft sensors, machine learning, and real-time data analytics. This technology aims to enhance supply chain resilience and broaden medical countermeasure capabilities by enabling on-site protein production in forward-deployed locations, similar to the impact of 3D printing. The project is divided into three phases: Phase I focuses on feasibility studies of existing BOND platforms, including protein production, glycosylation, lysate development, AI/ML analytics, and novel anti-infectious biologics. Phase II requires proposals for a robust, portable BOND system capable of producing GMP-like proteins with reproducible, scalable, and high-quality throughput, potentially involving ML/AI processing, sensor validation, lysate optimization, and resin modification. Phase III aims for an FDA-ready BOND device capable of meeting or surpassing existing FDA-approved protein production methods.
    1763769708869.pdf
    The CBD254-011
    1764968593783.pdf
    The CBD254-011 "OPEN TOPIC - Expeditionary Biologics-on-Demand (BOND)" solicitation seeks proposals to develop a portable, high-performance BOND system for point-of-care protein production. The objective is to maximize protein purity, potency, and quality through automated process control, incorporating soft sensors, machine learning, and real-time data analytics. These systems aim to enhance supply chain resilience and broaden medical countermeasure capabilities by enabling on-site protein production. Phase I focuses on feasibility studies using existing BOND platforms to produce high-purity proteins and explore AI/ML analytic techniques. Phase II requires proposals for a robust, portable BOND system capable of producing GMP-like proteins with reproducible, scalable, and high-quality throughput. Phase III's goal is an FDA-evaluation-ready BOND device capable of meeting or surpassing existing production methods of approved FDA proteins.
    1766361764129.pdf
    The CBD254-011
    PDF.html
    Please provide the text you would like summarized.
    Similar Opportunities
    OPEN TOPIC - Tactical CB Visualization -
    DOD
    The Department of Defense (DOD) is seeking innovative solutions through the SBIR program to enhance situational awareness and decision support for Warfighters operating in Chemical and Biological (CB) contested environments. The objective is to develop a tactical visualization tool or capability that integrates with Mission Oriented Protective Posture (MOPP) kits and various respirators, focusing on Human-Machine Interface (HMI) concepts to improve size, weight, and power (SWAP) demands. This opportunity is critical for ensuring effective communication and data visualization in dynamic battlefield scenarios, with potential dual-use applications in civilian sectors such as emergency response and manufacturing. Interested parties should note that the solicitation is set to open on January 7, 2026, with proposals due by January 28, 2026, and can find more information at the DOD SBIR website.
    Integrated Deployable Microsensors for Chemical Detection -
    DOD
    The Department of Defense (DoD) is seeking proposals for the development of integrated deployable microsensors for chemical detection under the SBIR program, specifically identified as CBD254-007. The objective is to design and fabricate low Size, Weight, Power, and Cost (SWaP-C) microsensors capable of detecting chemical warfare agents and pharmaceutical-based agents in vapor and aerosol forms, providing near real-time early warning in complex operational environments. This technology is crucial for enhancing rapid response and decision-making in both military and civilian applications, particularly for first responders in environmental detection and health monitoring. Proposals are due by January 28, 2026, with the opportunity opening on January 7, 2026, and further details can be found at the official solicitation agency website: https://www.dodsbirsttr.mil/topics-app/.
    Microphysiological systems to Assess Pretreatment Immunogenicity and Efficacy (MAGPIE) -
    DOD
    The Defense Threat Reduction Agency (DTRA) is seeking proposals for the development of Microphysiological Systems (MPS) to assess pretreatment immunogenicity and efficacy for vaccines against high-consequence pathogens, under the SBIR program. The primary objective is to create immune microphysiological systems (iMPS) that can accurately model human immune responses in vitro, thereby accelerating the discovery and validation of medical countermeasures essential for warfighter readiness. This initiative addresses the limitations of traditional in vitro and in vivo models, which are often slow and do not fully replicate the complexity of the human immune system, ultimately hindering rapid vaccine development. Interested parties should note that the solicitation is currently in the pre-release phase, with the open date set for January 7, 2026, and the application due date on January 28, 2026. For more information, please visit the official solicitation link at https://www.dodsbirsttr.mil/topics-app/.
    Shelf-Stable Nucleic Acid Synthesis Reagents for Field-Deployable Diagnostics -
    DOD
    The Department of Defense's Chemical and Biological Defense Program (CBDP) is seeking innovative solutions for the development of shelf-stable nucleic acid synthesis reagents aimed at enhancing rapid diagnostic capabilities in expeditionary environments. The primary objective is to create reagents that remain effective at room temperature, function reliably across a temperature range of -20°C to 55°C, and maintain a shelf life of at least 12 months, while also improving the yield of synthesized nucleic acids. These advancements are critical for enabling the rapid development and deployment of diagnostic assays in resource-constrained settings, particularly in response to emerging threats and infectious diseases. Interested parties should note that the solicitation number is CBD254-010, with the application due date set for January 28, 2026, and further details can be found at the provided source link: https://www.dodsbirsttr.mil/topics-app/.
    Far Forward Manufacturing of CBRN Sensors -
    DOD
    The Department of Defense is seeking proposals for the Far Forward Manufacturing (FFM) of Chemical, Biological, Radiological, and Nuclear (CBRN) sensors, aimed at enhancing the production capabilities of these critical technologies. The objective is to accelerate the development of sensors that are minimal in size, weight, and power consumption while enabling near real-time detection and transmission of threat information to warfighters, thereby reducing reliance on complex supply chains. This initiative is vital for ensuring force readiness and adaptability in modern warfare, with potential applications extending beyond the military to commercial sectors such as clinical diagnostics and environmental sensing. Interested parties should note that the solicitation is currently in the pre-release phase, with proposals due by January 28, 2026, and further details can be found at the provided source link: https://www.dodsbirsttr.mil/topics-app/.
    Complex Geometries for Extended Wear Respirators Towards Regenerable Particulate Matter Protection -
    DOD
    The Department of Defense (DOD) is seeking innovative solutions through the Small Business Innovation Research (SBIR) program to develop a rugged, 3D-printable, PFAS-free particulate filtration impactor system for extended-wear respirators in military environments. The objective is to create a regenerable filtration system that can be easily manufactured at the point of need, attach to existing respirators (such as the M50 and commercial half-masks), and effectively trap aerosols while minimizing breathing resistance and clogging during high aerobic activity. This initiative addresses the significant health risks posed by high levels of airborne particulate matter (PM10 and PM2.5) that military personnel face, particularly in operational environments. Interested parties should note that the solicitation is currently in pre-release, with the open date set for January 7, 2026, and the application due date on January 28, 2026. For more information, visit the DOD SBIR website at https://www.dodsbirsttr.mil/topics-app/.
    Unbiased Behavioral Discovery Platforms -
    DOD
    The Department of Defense (DoD), through the Defense Advanced Research Projects Agency (DARPA), is seeking innovative solutions for the development of unbiased behavioral discovery platforms aimed at enhancing the detection and development of medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats. The primary objective is to create automated, high-throughput technologies that can quantify novel animal behaviors in preclinical models, thereby improving the sensitivity and specificity of behavioral evaluations without requiring human annotation or invasive procedures. This initiative is critical for advancing defense health capabilities and ensuring rapid response to emerging threats, with a focus on ethical considerations and minimizing animal handling. The opportunity is currently in the pre-release phase, with applications opening on January 7, 2026, and closing on January 28, 2026. Interested parties can find more information and submit proposals through the official SBIR website.
    Novel Technologies for CWMD and Related Threats - Open Topic -
    DOD
    The Defense Threat Reduction Agency (DTRA) is seeking innovative solutions through its Small Business Innovation Research (SBIR) program to enhance the detection of weapons of mass destruction (WMD) and related threats. The objective is to develop novel technologies that utilize existing general-purpose military hardware or commercially available devices to detect WMD threats without relying on specialized sensors. This initiative is crucial for improving national security capabilities in a landscape where the commercial market for detection equipment is limited. The opportunity includes multiple phases: Phase I focuses on identifying feasible use cases and developing a proof of concept, while Phase II involves building and testing a prototype. The solicitation is currently in the pre-release stage, with an open date of January 7, 2026, and a close date of January 28, 2026. Interested parties can find more information and apply through the DOD SBIR website.
    Novel Sampling Tickets for Surface Enhanced Raman Spectroscopy (SERS) of Chemical and Biological (CB) Threat Materials -
    DOD
    The Department of Defense (DOD) is seeking innovative solutions for the development of novel sampling tickets designed for Surface Enhanced Raman Spectroscopy (SERS) to detect chemical and biological threat materials. The objective is to create physically semi-porous, flexible coupons that can enhance the sensitivity and selectivity of handheld Raman detectors, which currently require bulk samples and struggle with mixtures of materials. This initiative is crucial for improving the capabilities of fielded handheld Raman spectrometers, enabling them to detect trace amounts of hazardous substances such as toxins and fentanyl analogs from various surfaces. The solicitation is currently in the pre-release phase, with proposals due by January 28, 2026, and further details can be found at the DOD SBIR website.
    Li-ion 6T Battery Focused Open Topic -
    DOD
    The Department of Defense, specifically the Army, is seeking innovative solutions from small businesses through the Li-ion 6T Battery Focused Open Topic under the SBIR program. This opportunity focuses on addressing critical technical challenges related to MIL-PRF-32565 Li-ion 6T batteries, including advancements in power beaming for wireless charging, materials for thermal runaway mitigation, automated maintenance devices, and compact systems for combining batteries of varying specifications. These batteries are vital for military applications, enhancing fuel efficiency and operational capabilities. Phase I proposals are limited to $250,000 for a six-month feasibility study, with submissions due by January 28, 2026. For more information, interested parties can visit the official solicitation page at https://www.dodsbirsttr.mil/topics-app/.